Two General Sessions, One Reason to Be in Montréal - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Two General Sessions, One Reason to Be in Montréal

What to expect at the ASCP Annual Meeting 2026

  • By

  • Team ASCP

  • October 1, 2026

  • 3 min

Share

Clinical Report: Two General Sessions, One Reason to Be in Montréal

Overview

The 2026 Annual Meeting will feature keynotes and sessions focusing on advancements in pathology and laboratory medicine, including discussions on CAR-T therapy and digital pathology.

Background

The joint meeting of ASCP and CAP-ACP highlights the importance of continuous education in pathology and laboratory medicine.

Data Highlights

No numerical data or trial data available in the source material.

Key Findings

  • Donald L. Siegel will keynote on CAR-T therapy.
  • Pathology has played a role in the development of CAR-T therapies.
  • General sessions will cover digital pathology, precision diagnostics, workload, burnout, and patient advocacy.
  • Monalisa Sur will discuss key initiatives in pathology and laboratory medicine.

Clinical Implications

Attendees will learn about advancements in CAR-T therapy and digital pathology.

Conclusion

The 2026 Annual Meeting serves as a platform for discussing advancements in pathology.

Related Resources & Content

  1. ASCP, ASCP News, 2026 -- Leading Edge Scientist Dr. Donald L. Siegel, and CAP-ACP Subject Matter Experts, to Keynote the 2026 Annual Meeting
  2. retinal physician — What to Expect at ASRS 2026
  3. Drug Safety — Outcomes from the 2023 National Conference of the Canadian Medication Appropriateness and Deprescribing Network
  4. the analytical scientist — Eight Tips for Easy GC×GC
  5. Contact Lens Spectrum — A Look at 25 Years of GSLS and Specialty Lenses
  6. Laboratory Developed Tests | FDA
  7. Standards for Blood Banks and Transfusion Services
  8. M100 | Performance Standards for Antimicrobial Susceptibility Testing
  9. CAP Updates Cancer Protocols To Advance Breast Cancer Biomarker Reporting And GIST Molecular Testing - CAP
  10. Publication of the WHO Classification of Tumours, 6th Edition, Volume 1: Digestive System Tumours – IARC
  11. Interpretive Diagnostic Error Reduction - CAP
  12. Prehospital Resuscitation with Type O Whole Blood for Trauma and Hemorrhage | New England Journal of Medicine
  13. Balanced Component and Whole-Blood Transfusion Practices in US Trauma Centers | Emergency Medicine | JAMA Network Open | JAMA Network
  14. ASTCT Consensus Grading for Toxicities after Immune Effector Cell Therapy - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy
  15. Medical Therapy for Hormone Receptor-Positive, HER2-Negative Stage I-III Breast Cancer: ASCO Living Guideline, Version 2026.1.0
  16. Leading Edge Scientist Dr. Donald L. Siegel, and CAP-ACP Subject Matter Experts, to Keynote the 2026 Annual Meeting

Original Source(s)

Two General Sessions, One Reason to Be in Montréal

  • by Team ASCP

  • October 1, 2026

Related Content

Aptamer Tests Face the Validation Challenge

Clinical adoption will require reproducibility, quality control, and evidence of diagnostic utility

  • October 6, 2026

  • 3 min
Are Labs Ready for HPV Self-sampling?

How AI-assisted digital cytology could ease the burden on labs from increased cervical screening uptake

One Blood Spot, Two Omics Readouts

Single sample supports separate metabolite and lipid profiling in positive- and negative-ion modes

  • October 1, 2026

  • 2 min